Log in to save to my catalogue

2022-RA-1339-ESGO Treatment outcome of gestational trophoblastic disease at single center of Saudi A...

2022-RA-1339-ESGO Treatment outcome of gestational trophoblastic disease at single center of Saudi A...

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_proquest_journals_2729118769

2022-RA-1339-ESGO Treatment outcome of gestational trophoblastic disease at single center of Saudi Arabia

About this item

Full title

2022-RA-1339-ESGO Treatment outcome of gestational trophoblastic disease at single center of Saudi Arabia

Publisher

Kidlington: BMJ Publishing Group Ltd

Journal title

International journal of gynecological cancer, 2022-10, Vol.32 (Suppl 2), p.A425-A425

Language

English

Formats

Publication information

Publisher

Kidlington: BMJ Publishing Group Ltd

Subjects

More information

Scope and Contents

Contents

Introduction/BackgroundGestational trophoblastic disease (GTD) constitutes rare group of benign and malignant neoplasia with high cure rates. This study is aimed to evaluate the treatment outcomes in our populationMethodologyRetrospective analysis of patients treated with chemotherapy for GTD at King Fahad specialist Hospital Dammam from January 20...

Alternative Titles

Full title

2022-RA-1339-ESGO Treatment outcome of gestational trophoblastic disease at single center of Saudi Arabia

Identifiers

Primary Identifiers

Record Identifier

TN_cdi_proquest_journals_2729118769

Permalink

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_proquest_journals_2729118769

Other Identifiers

ISSN

1048-891X

E-ISSN

1525-1438

DOI

10.1136/ijgc-2022-ESGO.913

How to access this item